Clinical TrialID 4888
GASC1 Inhibitor Caffeic Acid for Squamous Esophageal Cell Cancer (ESCC)
NCT04648917
Esophagus Cancer, Stage III
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 4888
- Evidence Id
- 4888
- Core Evidence Id
- 4888
- Source Clinical Trial Id
- 4865
- Herb2 Clinical Trial Id
- HBCT004865
- Nct Id
- NCT04648917
- Title
- GASC1 Inhibitor Caffeic Acid for Squamous Esophageal Cell Cancer (ESCC)
- Status
- Phase
- Phase 3
- Study Result
- No
- Study Condition
- Esophagus Cancer, Stage III
- Study Type
- Interventional
- Study Design
- Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
- Intervention
- DRUG: Caffeic acid
- Intervention Allocation
- Randomized
- Intervention Model
- Parallel
- Intervention Mask
- Quadruple
- Intervention Purpose
- Treatment
- Gender
- All
- Age
- Adult, Older_Adult
- Enrollment
- 80
- Outcome Measure
- overall survival (OS), The percentage of 1 year overall survival (OS) after random allocation. The follow-up will be done every 3 months through phone call, investigator visiting, and medical recording review., 1 year
- Sponsor Collaborator
- The First Affiliated Hospital of Henan University of Science and Technology
- Funded By
- OTHER
- Location
- Anyang Tumor Hospital, Anyang, Henan, China|The Clinical Medical College, The First Affiliated Hospital of Henan University of Science and Technology, Luoyang, Henan, 471003, China|Nanyang Central Hospital, Nanyang, Henan, 473000, China
- Other Id
- GiCAEC-LY002
- Start Date
- 2019-05-01
- Primary Completion Date
- 2021-05-01
- Completion Date
- 2022-05-01
- First Posted
- 2020-12-02
- Results First Posted
- Last Update Posted
- 2020-12-03
- Study Document
- Study Url
- https://clinicaltrials.gov/study/NCT04648917
- Title Cn
- Title En
- GASC1 Inhibitor Caffeic Acid for Squamous Esophageal Cell Cancer (ESCC)
- Bilingual Status
- semi_complete